Royalty Pharma plc
RPRX
Peringkat dalam Saham
#867
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Harga Saham
$62.21
Kapitalisasi Pasar
$27.70B
Perubahan (1 hari)
3.22%
Perubahan (1 tahun)
69.83%
Negara
US
Perdagangan Royalty Pharma plc (RPRX)
Kategori
Healthcare
Rasio P/S untuk Royalty Pharma plc (RPRX)
Rasio P/S per October 2026 TTM: 10.31
Menurut laporan keuangan dan harga saham terbaru dari Royalty Pharma plc, rasio P/S saat ini (TTM) adalah 10.31. Pada akhir 2023, rasio P/S perusahaan adalah 5.34.
Riwayat rasio P/S untuk Royalty Pharma plc dari 2015 hingga 2026
Rasio P/S pada akhir setiap tahun
| Tahun | Rasio P/S | Mengubah |
|---|---|---|
| 2026 (TTM) | 10.31 | 104.99% |
| 2024 | 5.03 | -5.87% |
| 2023 | 5.34 | -30.98% |
| 2022 | 7.74 | 7.16% |
| 2021 | 7.22 | -21.12% |
| 2020 | 9.15 | 5.36% |
| 2019 | 8.69 | -1.07% |
| 2018 | 8.78 | -10.97% |
| 2017 | 9.86 | -31.45% |
| 2016 | 14.39 | -11.98% |
| 2015 | 16.35 | 0.00% |
Rasio P/S untuk perusahaan sejenis atau pesaing
| Perusahaan | Rasio P/S | Perbedaan Rasio P/S | Negara |
|---|---|---|---|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| 15.12 | 46.67% |
US
|
|
| 2.36 | -77.11% |
HK
|
